Gene therapy: Industrial strength

Nature. 2016 Sep 8;537(7619):S57-9. doi: 10.1038/537S57a.
No abstract available

MeSH terms

  • Animals
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use
  • Central Nervous System Diseases / genetics
  • Central Nervous System Diseases / therapy
  • Clinical Trials as Topic
  • Dependovirus / genetics
  • Dogs
  • Drug Approval
  • Genetic Therapy / adverse effects
  • Genetic Therapy / economics
  • Genetic Therapy / trends*
  • Genetic Vectors / adverse effects
  • Genetic Vectors / genetics
  • Hematologic Diseases / genetics
  • Hematologic Diseases / therapy
  • Herpesvirus 1, Human / genetics
  • Humans
  • Lentivirus / genetics
  • Neoplasms / genetics
  • Neoplasms / therapy
  • Patient Safety
  • Precision Medicine / adverse effects
  • Precision Medicine / economics
  • Precision Medicine / methods*
  • Precision Medicine / trends*
  • Rare Diseases / genetics
  • Rare Diseases / therapy
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal